ConductScience.org, home

Paper41374009

Dysapolipoproteinaemia Influences the Relationship Between Very Low-Density Lipoprotein Cholesterol and Intra-Pancreatic Fat Deposition in Humans.

Liu Y and 5 others. Nutrients, 2025. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Dysapolipoproteinaemia Influences the Relationship Between Very Low-Density Lipoprotein Cholesterol and Intra-Pancreatic Fat Deposition in Humans. Papers, record 41374009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41374009

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dysapolipoproteinaemia Influences the Relationship Between Very Low-Density Lipoprotein Cholesterol and Intra-Pancreatic Fat Deposition in Humans.
PubMed
Journal
Nutrients
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-12-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu YYutong
2Skudder-Hill LLoren
3Ko JJuyeon
4Shamaitijiang XXiatiguli
5Sequeira-Bisson IRIvana R
6Petrov MSMaxim Shttps://orcid.org/0000-0002-5923-9062

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cholesterol, VLDLMajor topic
PancreasMajor topic
DyslipidemiasMajor topic
Humans
Male
Female
Middle Aged
Adult
Apolipoproteins B
Magnetic Resonance Imaging
Apolipoprotein C-III
Apolipoprotein C-II
Aged

Source PubMed

Download CSV of topics

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140446943Relationship of Intrapancreatic Fat Deposition With Pancreatic Cancer Differs According to Carcinoma Types.Gastroenterology2025https://conductscience.org/library/papers/40446943PubMed
211034934VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.Circulation2000https://conductscience.org/library/papers/11034934PubMed
341118532Excessive Intrapancreatic Fat Deposition and Risk of Pancreatic Diseases: Longitudinal Cohort Evidence From a Systematic Review With Population-Attributable Fraction Analysis.Am J Gastroenterol2025https://conductscience.org/library/papers/41118532PubMed
415734858Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?Diabetes2005https://conductscience.org/library/papers/15734858PubMed
540015555Relationship of fat in the pancreas with cardiovascular disease: A systematic review and meta-analysis.Obes Rev2025https://conductscience.org/library/papers/40015555PubMed
640356715Intra-Pancreatic Fat Deposition and Pancreatitis: Insights from the COSMOS Program.Diabetes Metab Syndr Obes2025https://conductscience.org/library/papers/40356715PubMed
740840644Fatty Pancreas Disease: An Integrated Study on Frozen Tissues Shows Distinct Compartments of Interlobular/Intralobular, Intra-Acinar, and Intra-Islet Fat Deposition.Lab Invest2025https://conductscience.org/library/papers/40840644PubMed
834880411Intra-pancreatic fat deposition: bringing hidden fat to the fore.Nat Rev Gastroenterol Hepatol2022https://conductscience.org/library/papers/34880411PubMed
931477272Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach.Biochem Biophys Res Commun2019https://conductscience.org/library/papers/31477272PubMed
1037972731Apolipoprotein C3: form begets function.J Lipid Res2024https://conductscience.org/library/papers/37972731PubMed
1135234845Fat Distribution Within the Pancreas According to Diabetes Status and Insulin Traits.Diabetes2022https://conductscience.org/library/papers/35234845PubMed
1239743538Gender-specific correlations between serum lipid profiles and intra-pancreatic fat deposition: a cross-sectional study.Lipids Health Dis2025https://conductscience.org/library/papers/39743538PubMed
1336267630Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights.Front Cardiovasc Med2022https://conductscience.org/library/papers/36267630PubMed
1416483925Fatty acids and insulin resistance: a perfect storm.Mol Cell2006https://conductscience.org/library/papers/16483925PubMed
1519622837Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions.J Lipid Res2010https://conductscience.org/library/papers/19622837PubMed
1628369092Quantification of intrapancreatic fat in type 2 diabetes by MRI.PLoS One2017https://conductscience.org/library/papers/28369092PubMed
1732246380Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: a 6-year computed tomography-based cohort study.J Gastroenterol2020https://conductscience.org/library/papers/32246380PubMed
1839377129Relationship of high-density lipoprotein subfractions and apolipoprotein A-I with fat in the pancreas.Diabetes Obes Metab2025https://conductscience.org/library/papers/39377129PubMed
1915292332
Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.
J Clin Endocrinol Metab2004https://conductscience.org/library/papers/15292332PubMed
2011916950Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice.Diabetes2002https://conductscience.org/library/papers/11916950PubMed

See all 65 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42199606Clinical Relevance and Utility of Serum APOC2 Levels in Patients with Type 2 Diabetes Mellitus: A Comparative Study on Subjects with and without Pyogenic Liver Abscess.Hepat Med2026https://conductscience.org/library/papers/42199606PubMed
41757662Identification of Common Blood Metabolic Derangements Using Magnetic Resonance Signatures of the Pancreas and Liver.Diabetes Obes Metab2026https://conductscience.org/library/papers/41757662PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOB338PubTator's text mininghttps://conductscience.org/library/genes/338NCBI Gene
APOC2344PubTator's text mininghttps://conductscience.org/library/genes/344NCBI Gene
APOC3345PubTator's text mininghttps://conductscience.org/library/genes/345NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41374009

GET https://conductscience.org/api/papers/v1/41374009/references?page=2